Crohn’s Disease (CD) Treatment Market Growth Outlook Through 2024-2033

Spread the love

Overview and Scope

Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that causes inflammation and swelling of the tissues in the digestive tract. Crohn’s disease (CD) treatment involves various approaches, therapies, medications and interventions to manage and control the symptoms and complications of a chronic inflammatory condition.

Sizing and Forecast

The crohn’s disease (cd) treatment market size has grown strongly in recent years. It will grow from $11.13 billion in 2023 to $11.76 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%.  The  growth in the historic period can be attributed to rising prevalence of crohn’s disease, growing awareness of the disease, government initiatives, changing lifestyle.

The crohn’s disease (cd) treatment market size is expected to see steady growth in the next few years. It will grow to $14.22 billion in 2028 at a compound annual growth rate (CAGR) of 4.9%.  The growth in the forecast period can be attributed to growing demand for combination therapies, increasing adoption of biologics, investments in research and development on crohn’s disease (cd) treatments. Major trends in the forecast period include development biologic drugs, innovative products, advanced diagnostic tools, biosimilars adoption.

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/crohn’s-disease-cd-treatment-global-market-report

Segmentation & Regional Insights

The crohn’s disease (cd) treatment market covered in this report is segmented –

1) By Drug Type: Antibiotics; Amino Salicylates; Corticosteroids; Immunomodulators; Other Drug Types

2) By Route of Administration: Oral; Injectable

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Drug Stores

North America was the largest region in the Crohn’s disease (CD) treatment market in 2023. The regions covered in Crohn’s disease (CD) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12902&type=smp

Major Driver Impacting Market Growth

The increasing prevalence of inflammatory bowel diseases is expected to propel the growth of the Crohn’s disease (CD) treatment market going forward. Inflammatory bowel disease (IBD) is a group of chronic inflammatory disorders primarily affecting the gastrointestinal (GI) tract. Crohn’s disease (CD) treatment offers relief from symptoms, reduces inflammation, promotes remission and enhances the overall quality of life for individuals suffering from chronic inflammatory bowel disease. For instance, in May 2021, according to BioMed Central Ltd., a UK-based scientific open-access publisher, it is expected that between 2020 and 2035, there will be 69 thousand Inflammatory bowel disease cases in Iran, 220 thousand cases in the Middle East, 2.2 million cases in India and 4.5 million cases in East Asia. Therefore, the increasing prevalence of inflammatory bowel diseases drives the Crohn’s disease (CD) treatment market.

Key Industry Players

Major players in the crohn’s disease (cd) treatment market are  Pfizer Inc., Johnson and Johnson Ltd., Merck and Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Ferring B.V., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC.

The crohn’s disease (cd) treatment market report table of contents includes:

 

  1. Executive Summary
  2. Crohn’s Disease (CD) Treatment Market Characteristics
  3. Crohn’s Disease (CD) Treatment Market Trends And Strategies
  4. Crohn’s Disease (CD) Treatment Market – Macro Economic Scenario
  5. Global Crohn’s Disease (CD) Treatment Market Size and Growth

.

.

.

  1. Global Crohn’s Disease (CD) Treatment Market Competitive Benchmarking
  2. Global Crohn’s Disease (CD) Treatment Market Competitive Dashboard
  3. Key Mergers And Acquisitions In The Crohn’s Disease (CD) Treatment Market
  4. Crohn’s Disease (CD) Treatment Market Future Outlook and Potential Analysis
  5. Appendix

Top Major Players:

  • Pfizer Inc
  • Johnson and Johnson Ltd.
  • Merck and Co. Inc
  • AbbVie Inc
  • Novartis AG

Explore the trending research reports from TBRC:

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company  

Twitter: https://twitter.com/tbrc_info  

Facebook: https://www.facebook.com/TheBusinessResearchCompany  

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ  

Blog: https://blog.tbrc.info/  

Healthcare Blog: https://healthcareresearchreports.com/  

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model   


Spread the love

About Top PR News

TopPRnews Leads Drives Search Engine Visibility For Your Press Release Content. Our Global Network Reaches Important Contacts, Media Partners And Websites And Journalists. Happy Postings! If You Have Any Queries Please Contact Official Mail At [[email protected]}

View all posts by Top PR News →